I
In Ho Chang
Researcher at Chung-Ang University
Publications - 175
Citations - 1546
In Ho Chang is an academic researcher from Chung-Ang University. The author has contributed to research in topics: Bladder cancer & Cancer. The author has an hindex of 19, co-authored 147 publications receiving 1300 citations. Previous affiliations of In Ho Chang include Seoul National University & Korea Electric Power Corporation.
Papers
More filters
Journal ArticleDOI
Vascularization Methods for Tissue Engineers
TL;DR: This review gives a brief overview of the processes and factors involved in the vascularization and angiogenesis and summarizes the different strategies to overcome the issue of slow vascularized tissues post implantation in a range of tissue-engineered substitutes.
Journal ArticleDOI
Immunotherapeutic effects of recombinant Bacillus Calmette–Guérin containing sic gene in ex vivo and in vivo bladder cancer models
Jung Hoon Kim,Joongwon Choi,Mirinae Kim,Su Kang,Young Wook Choi,Se Young Choi,Sunghyun Kim,In Ho Chang +7 more
TL;DR:
Epidemiology of Antimicrobial-Resistance in Sexually Transmitted Infections in Korea: Implications for Rational Treatment
Jung Hoon Kim,In Ho Chang +1 more
Journal ArticleDOI
The Present and Future of the Cancer Microenvironment Bioprinting
TL;DR: This review will focus on cancer biology and limitations with current cancer models and discusses vascular structures bioprinting that are critical to the construction of complex 3D cancer organoids.
Journal ArticleDOI
Mp21-04 establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway
Jung Won Choe,Kyung Do Kim,Young Tae Moon,Jong Kyou Kwon,In Ho Chang,Jung Hoon Kim,Jae Duck Choi,Seung Hyun Ahn,Min Su Kim,So Yeon Lee,Jae Hyung Ryu,Sang Ho Park +11 more
TL;DR: The data reveal that methylation of the tumor suppressor gene Wif-1 occurs early in the schistosomiasis and carcinogen exposed bladder urothelium and future work will determine the diagnostic, prognostic, and therapeutic potential of this early methylation event.